MD DME LLC – Trademark Portfolio

Entity Type: 16

MD DME LLC holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 12 trademarks are registered and 2 are pending. Notable registered marks include CURASIL, POSTSIL, ALGIHEAL, CURAFOAM, and HYDRAPAD. The owner is based in San Antonio, TX.

21222 Gathering Oak

Ste. 103

San Antonio, TX 78260

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MD DME LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does MD DME LLC have?

MD DME LLC has 14 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 pending.

What trademark classes does MD DME LLC file in?

MD DME LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MD DME LLC's most well-known trademarks?

MD DME LLC's registered trademark portfolio includes well-known marks such as CURASIL, POSTSIL, ALGIHEAL, CURAFOAM, and HYDRAPAD. These are among 12 currently registered trademarks in the portfolio.

What is MD DME LLC's trademark registration success rate?

MD DME LLC has a 100% trademark registration rate, with 12 out of 12 resolved applications resulting in successful registration. Currently, 2 applications are pending review.